IGF-DES 1,3Explore study findings
Why weight gain and kidney filtration told different stories in rats
2 numbered sourcesSource years 1989, 1994
Short amino-acid chains held together by peptide bonds can carry growth signals. IGF-DES 1,3 commonly denotes des(1–3)IGF-1, a shortened version of insulin-like growth factor 1 that lacks residues one through three. In an animal experiment after a temporary loss of kidney blood flow, investigators asked whether changes in whole-body growth measures were accompanied by better kidney filtration. [1, 2]
No recent primary study directly repeating this comparison was identified. In the older 1994 study, rats experienced acute kidney injury after temporary blockage of the arteries supplying both kidneys. The investigators compared rats receiving a control solution with groups receiving full-length IGF-1, des(1–3)IGF-1 or another engineered IGF-1 analogue called LR3. They measured body weight, nitrogen retention and kidney-related endpoints over the study period. [1]
The groups receiving the growth factors gained more weight and retained more nitrogen than the injured controls. Nitrogen retention is an indirect measure of the balance between nitrogen taken in and lost, and it can help describe protein metabolism. Serum urea was lower with full-length IGF-1 and with des(1–3)IGF-1. The authors did not find a corresponding improvement in the kidneys' filtration rate with these compounds. A lower urea level alone therefore could not establish better filtration in the experimental animals. [1]
The research separates measurements of whole-body metabolism from measures of the injured organ. It was conducted in rats, with a specific cause of kidney injury and a short observation period. The results describe how those animals responded and do not establish that des(1–3)IGF-1 treats kidney injury in people. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
